rethinkTHC Search
Menu
Study breakdown

Comprehensive Review of CBD's Potential for Brain Disorders

Narrative ReviewPreliminary evidence
The takeaway

Review of 170 articles maps CBD's anti-inflammatory and neuroprotective mechanisms, proposing metabolomics as the next frontier.

Neuroscience researchers and clinicians considering CBD.

170 articles reviewed across neurological and neuropsychiatric conditions

What the researchers found

CBD antagonizes pro-inflammatory cytokines, regulates oxidative stress, downregulates TNF-alpha, restores BDNF and serotonin across neurological disorders.

Why it matters

Maps CBD mechanisms across brain disorders in one reference; proposes metabolomics for personalized therapy.

The numbers in context

170 articles (41% of screened); TNF-alpha downregulation, BDNF restoration, serotonin recovery

How the study worked

Narrative review of 170 articles (41% of screened) from PubMed, Web of Science, and Scopus.

What this study cannot tell us

Narrative review. Mostly preclinical. No new data. Breadth limits depth.

How to read the evidence

Broad narrative review of mostly preclinical evidence.

When this study was published

Published in 2024.

The bigger picture

Translating preclinical CBD findings into clinical treatments remains the challenge.

Questions still open

  • Can metabolomics predict CBD response?
  • Which conditions have strongest clinical CBD evidence?

Common questions

How does CBD fight brain inflammation?
By antagonizing cytokines, downregulating TNF-alpha, and restoring BDNF and serotonin.
What is metabolomics?
Study of metabolic small molecules that could predict CBD treatment response.

Read the original research

A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders.

Journal of cannabis research, 6(1), 14

Citation

Omotayo, Oluwadara Pelumi; Lemmer, Yolandy; Mason, Shayne. (2024). A narrative review of the therapeutic and remedial prospects of cannabidiol with emphasis on neurological and neuropsychiatric disorders.. Journal of cannabis research, 6(1), 14. https://doi.org/10.1186/s42238-024-00222-2

Explore the wider topic